ATE177008T1 - Verwendung von toremifene für die behandlung von sle - Google Patents

Verwendung von toremifene für die behandlung von sle

Info

Publication number
ATE177008T1
ATE177008T1 AT93923058T AT93923058T ATE177008T1 AT E177008 T1 ATE177008 T1 AT E177008T1 AT 93923058 T AT93923058 T AT 93923058T AT 93923058 T AT93923058 T AT 93923058T AT E177008 T1 ATE177008 T1 AT E177008T1
Authority
AT
Austria
Prior art keywords
treatment
toremifene
sle
glucocorticoid
estrogen
Prior art date
Application number
AT93923058T
Other languages
English (en)
Inventor
Junpei Itoh
Osamu Miyazaki
Hisao Ekimoto
Michinori Koyama
Tetsushi Saino
Lauri Kangas
Anni Warri
Christer Granberg
Original Assignee
Nippon Kayaku Kk
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Kayaku Kk, Orion Yhtymae Oy filed Critical Nippon Kayaku Kk
Application granted granted Critical
Publication of ATE177008T1 publication Critical patent/ATE177008T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Transplantation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Steroid Compounds (AREA)
AT93923058T 1992-10-27 1993-10-26 Verwendung von toremifene für die behandlung von sle ATE177008T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP31077292 1992-10-27

Publications (1)

Publication Number Publication Date
ATE177008T1 true ATE177008T1 (de) 1999-03-15

Family

ID=18009292

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93923058T ATE177008T1 (de) 1992-10-27 1993-10-26 Verwendung von toremifene für die behandlung von sle

Country Status (12)

Country Link
US (3) US6355688B1 (de)
EP (2) EP0667768B1 (de)
KR (1) KR100303634B1 (de)
CN (1) CN1053337C (de)
AT (1) ATE177008T1 (de)
AU (1) AU5286693A (de)
DE (1) DE69323759T2 (de)
DK (1) DK0667768T3 (de)
ES (1) ES2128441T3 (de)
GR (1) GR3029682T3 (de)
NO (2) NO314533B1 (de)
WO (1) WO1994009764A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6395494B1 (en) 1993-05-13 2002-05-28 Neorx Corporation Method to determine TGF-β
DE69435137D1 (de) * 1993-05-13 2008-10-16 Poniard Pharmaceuticals Inc Prävention und behandlung von pathologien, die mit einer abnormalen proliferationglatter muskelzellen verbunden sind
US5521198A (en) 1993-12-21 1996-05-28 Eli Lilly And Company Methods of inhibiting autoimmune diseases
AU746007B2 (en) * 1997-02-09 2002-04-11 Pharmos Corporation Enhanced anti-angiogenic activity of permanently charged derivatives of steroid hormones
AU6508898A (en) 1997-03-06 1998-09-22 Nashua Corporation Improved display
WO1998046588A2 (en) 1997-04-11 1998-10-22 Neorx Corporation Compounds and therapies for the prevention of vascular and non-vascular pathologies
US8278291B1 (en) 1999-08-13 2012-10-02 Curadis Gmbh Treatment of wrinkles and strias with 4-hydroxyandrostenedione or a derivative thereof
US20020013327A1 (en) * 2000-04-18 2002-01-31 Lee Andrew G. Compositions and methods for treating female sexual dysfunction
US6613083B2 (en) 2001-05-02 2003-09-02 Eckhard Alt Stent device and method
US7069444B2 (en) * 2002-01-25 2006-06-27 Brent A. Lowensohn Portable wireless access to computer-based systems
WO2009149081A1 (en) * 2008-06-02 2009-12-10 Novelmed Therapeutics, Inc. Method for treating inflammatory conditions
ES2675093T3 (es) 2009-02-09 2018-07-06 Valspar Sourcing, Inc. Sistema de pintura y tintura no absorbentes de los infrarrojos y teñibles en tienda
AU2010210344B2 (en) 2009-02-09 2016-02-25 Swimc Llc In-store tintable non-infrared-absorptive paint and stain system
MX2012015085A (es) 2010-07-01 2013-03-05 Valspar Sourcing Inc Composicion de revestimiento reflectante infrarrojo de dos partes.
MY161750A (en) 2010-10-20 2017-05-15 Valspar Sourcing Inc Water-based coating system with improved moisture and heat resistance
RU2572504C1 (ru) * 2013-12-26 2016-01-10 Андрей Константинович Иорданишвили Способ лечения лучевой сиалоаденопатии
MA43805A (fr) 2016-02-23 2018-11-28 Advanced Environmental Recycling Tech Inc Compositions et procédés pour réduire la température de surface d'articles composites
EP3562682A1 (de) 2017-01-01 2019-11-06 Advanced Environmental Recycling Technologies, Inc Verfahren zur beschichtung von verbundartikeln

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU172948B (hu) 1976-02-05 1979-01-28 Gyogyszerkutato Intezet Sposob poluchenija osnovnykh proizvodnykh trifenil-alkenov
EP0002097B1 (de) 1977-08-22 1981-08-05 Imperial Chemical Industries Plc Triphenylalken-Derivate, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten
DE3046719C2 (de) 1980-12-11 1983-02-17 Klinge Pharma GmbH, 8000 München 1,1,2-Triphenyl-but-1-en-Derivate, Verfahren zu ihrer Herstellung und Arzneimittel
FI67538C (fi) 1982-05-27 1985-04-10 Farmos Oy Foerfarande foer framstaellning av (z)-1,2-difenyl-1-(4-(2-(n n-dimetylamino)etoxi)fenyl)-1-buten
GB2126576B (en) * 1982-06-25 1985-06-19 Farmos Group Limited Alkane and alkene derivatives
US5348729A (en) * 1988-11-30 1994-09-20 The United States Of America As Represented By The Department Of Health And Human Services Evaluative means for detecting inflammatory reactivity
US4990538A (en) * 1989-08-23 1991-02-05 Harris Adrian L Use of toremifene and its metabolites for the reversal of multidrug resistance of cancer cells against cytotoxic drugs
JPH04312526A (ja) * 1991-04-09 1992-11-04 Fujisawa Pharmaceut Co Ltd 骨疾患治療剤

Also Published As

Publication number Publication date
WO1994009764A1 (en) 1994-05-11
CN1053337C (zh) 2000-06-14
US6355688B1 (en) 2002-03-12
KR100303634B1 (ko) 2001-11-22
DE69323759T2 (de) 1999-07-22
GR3029682T3 (en) 1999-06-30
AU5286693A (en) 1994-05-24
CN1100930A (zh) 1995-04-05
NO317544B1 (no) 2004-11-08
EP0667768A1 (de) 1995-08-23
US6387958B1 (en) 2002-05-14
DK0667768T3 (da) 1999-09-27
NO20025179D0 (no) 2002-10-28
EP0667768B1 (de) 1999-03-03
DE69323759D1 (de) 1999-04-08
US20020107231A1 (en) 2002-08-08
NO951596L (no) 1995-04-26
EP0776661A1 (de) 1997-06-04
NO314533B1 (no) 2003-04-07
US6458848B1 (en) 2002-10-01
ES2128441T3 (es) 1999-05-16
NO951596D0 (no) 1995-04-26
NO20025179L (no) 1995-04-26
KR940008677A (ko) 1994-05-16

Similar Documents

Publication Publication Date Title
DE69323759D1 (de) Verwendung von toremifene für die behandlung von sle
DE69414176D1 (de) Verfahren zur Herstellung von N-Acyl-N,N',N'-Ethylendiamintriessigsäurederivaten
FI933946A7 (fi) Hypoglykeemisinä aineina ja Alzheimerin taudin hoidossa käyttökelpoisia yhdisteitä
ATE150299T1 (de) Verwendung von derivaten des 4-phenyl-1,2,3,4- tetrahydro-1-naphthalenamins zur behandlung von psychose, entzündung und als immununterdrücker
IT1236831B (it) Apparecchio per il trattamento dell'intestino in particolare per enteroclisma
FI930387A7 (fi) Stabiili hoitoshampoo, joka sisältää rasvahappoa
ATE303140T1 (de) Tramadolhaltiges arzneimittel mit gesteuerter wirkstoffabgabe
DE69331605D1 (de) Verwendung von phenserin zur herstellung von medikamenten zur behandlung von kognitiven störungen
AU5778090A (en) 11B-aryl-4-estrenes, process for their preparation as well as their use as pharmaceutical agents
DE3583220D1 (de) Verwendung von dipeptidderivaten fuer die herstellung von arzneimitteln zur behandlung von an amyotropher lateralsklerose erkrankten.
PT862575E (pt) Novos derivados de geranilgeranilo processo para a sua preparacao e composicoes farmaceuticas relacionadas
IT8468281A1 (it) Proglumide e composizioni farmaceutiche che la contengono per l'impiego nella terapia di affezioni neoplastiche.
EP0295695A3 (en) New pyrazoline derivatives and agents for treating cerebnew pyrazoline derivatives and agents for treating cerebrovascular diseases containing the same as active ingredrovascular diseases containing the same as active ingredient ient
EE9600023A (et) Fenüültsükloheksüülkarboksüülhappeamiidid, nende valmistamismeetod, kasutamine ravimite valmistamiseks, nimetatud ühendeid sisaldavad ravimid ja nende valmistamismeetod
DE69214608D1 (de) Kristallmodifikation von 2-(3-Methylanilino)-3-Methyl-6-Diethylaminofluoran, Verfahren zur dessen Herstellung und Aufzeichnungsmaterial, welches diese Kristallmodifikation enthält
AU4012893A (en) Method for inducing the acrosome reaction in human and animal spermatozoa
DE68920896D1 (de) N2-(1-Carboxy-3-phenylpropyl)-L-lysinderivate und Verfahren für die Herstellung von Lysinopril mit Hilfe dieser Verbindung.
DE69408484D1 (de) 6,7-Dialkoxy-3,4-dihydroisochinolin-8-ol, Verfahren für seine Herstellung und die Verbindung verwendendes Verfahren für die Herstellung von 6,7-Dialkoxy-1,2,3,4-tetrahydroisochinolin-8-ol
AU634584B2 (en) Aroyl-ureas
JPS5583758A (en) Novel 3*44diazaabicyclo*4*1*0*heptenee*2**onee *5**its manufacture and medicine containing it
DE69300037D1 (de) Verwendung von Bucillamin zur Herstellung eines Arzneimittels zur Behandlung von Cystinuria.
DE3861271D1 (de) Basisch substituierte benzofurancarbonsaeureamide, verfahren zu ihrer herstellung und sie enthaltende therapeutische mittel.
IT1170238B (it) Impiego di ibuprofene e flurbiprofene nella cura dell'erpete
DE69632117D1 (de) Verwendung von 8,9-Dehydroestron zur Herstellung eines Arzneimittels zur Behandlung von durch freie Radikale verursachte Krankheiten
IT1252659B (it) Procedimento per la depurazione dell'1,1,1-trifluoro-2-fluoroetano e dell'1,1,1-trifluoro-2,2-dicloroetano

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee